US Stock MarketDetailed Quotes

Candela Medical (CDLA)

Watchlist
  • 0.000
  • 0.0000.00%
Close May 13 09:30 ET
0Market Cap0.00P/E (TTM)

Candela Medical (CDLA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
43.45%-17.52M
-30.97M
Net income from continuing operations
-25.80%-43.89M
---34.89M
Operating gains losses
-38.36%810K
--1.31M
Depreciation and amortization
-7.65%16.66M
--18.04M
Deferred tax
-44.45%2.61M
--4.7M
Other non cash items
-563.64%-459K
--99K
Change In working capital
112.95%3.03M
---23.41M
-Change in receivables
240.15%23M
---16.41M
-Change in inventory
114.10%5.12M
---36.31M
-Change in prepaid assets
-168.05%-3.09M
--4.54M
-Change in payables and accrued expense
-224.90%-25.45M
--20.38M
-Change in other working capital
-21.22%3.46M
--4.39M
Cash from discontinued investing activities
Operating cash flow
43.45%-17.52M
---30.97M
Investing cash flow
Cash flow from continuing investing activities
42.32%-11.63M
-20.17M
Net PPE purchase and sale
42.32%-11.63M
---20.17M
Cash from discontinued investing activities
Investing cash flow
42.32%-11.63M
---20.17M
Financing cash flow
Cash flow from continuing financing activities
43.03%58.76M
41.08M
Net issuance payments of debt
869.82%58.97M
--6.08M
Net other financing activities
-100.59%-208K
--35M
Cash from discontinued financing activities
Financing cash flow
43.03%58.76M
--41.08M
Net cash flow
Beginning cash position
-26.91%27.5M
--37.63M
Current changes in cash
394.29%29.61M
---10.06M
Effect of exchange rate changes
2,497.01%1.61M
---67K
End cash Position
113.50%58.72M
--27.5M
Free cash flow
43.00%-29.15M
---51.14M
Currency Unit
USD
USD
Audit Opinions
Unqualified Opinion
--
(FY)Dec 31, 2020(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 43.45%-17.52M-30.97M
Net income from continuing operations -25.80%-43.89M---34.89M
Operating gains losses -38.36%810K--1.31M
Depreciation and amortization -7.65%16.66M--18.04M
Deferred tax -44.45%2.61M--4.7M
Other non cash items -563.64%-459K--99K
Change In working capital 112.95%3.03M---23.41M
-Change in receivables 240.15%23M---16.41M
-Change in inventory 114.10%5.12M---36.31M
-Change in prepaid assets -168.05%-3.09M--4.54M
-Change in payables and accrued expense -224.90%-25.45M--20.38M
-Change in other working capital -21.22%3.46M--4.39M
Cash from discontinued investing activities
Operating cash flow 43.45%-17.52M---30.97M
Investing cash flow
Cash flow from continuing investing activities 42.32%-11.63M-20.17M
Net PPE purchase and sale 42.32%-11.63M---20.17M
Cash from discontinued investing activities
Investing cash flow 42.32%-11.63M---20.17M
Financing cash flow
Cash flow from continuing financing activities 43.03%58.76M41.08M
Net issuance payments of debt 869.82%58.97M--6.08M
Net other financing activities -100.59%-208K--35M
Cash from discontinued financing activities
Financing cash flow 43.03%58.76M--41.08M
Net cash flow
Beginning cash position -26.91%27.5M--37.63M
Current changes in cash 394.29%29.61M---10.06M
Effect of exchange rate changes 2,497.01%1.61M---67K
End cash Position 113.50%58.72M--27.5M
Free cash flow 43.00%-29.15M---51.14M
Currency Unit USDUSD
Audit Opinions Unqualified Opinion--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More